About MyoPowers Medical Technologies
MyoPowers Medical Technologies is a company based in Besancon (France) founded in 2004.. MyoPowers Medical Technologies has raised $32.99 million across 5 funding rounds from investors including Bpifrance, Truffle Capital and Novartis Venture Fund. MyoPowers Medical Technologies operates in a competitive market with competitors including Axonics, Amber Therapeutics, NeuSpera Medical, UroMems and Levee Medical, among others.
- Headquarter Besancon, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$32.99 M (USD)
in 5 rounds
-
Latest Funding Round
$1.13 M (USD), Debt – Venture
Jun 22, 2015
-
Investors
Bpifrance
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MyoPowers Medical Technologies
MyoPowers Medical Technologies has successfully raised a total of $32.99M across 5 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $1.13 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Debt – Venture — $1.1M
-
First Round
First Round
(01 May 2010)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Debt – Venture - MyoPowers Medical Technologies | Valuation |
investors |
|
| Jun, 2015 | Amount | Series B - MyoPowers Medical Technologies | Valuation | Truffle Capital | |
| Apr, 2013 | Amount | Series B - MyoPowers Medical Technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MyoPowers Medical Technologies
MyoPowers Medical Technologies has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, Truffle Capital and Novartis Venture Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in innovative life science companies globally.
|
Founded Year | Domain | Location | |
|
Truffle Capital is recognized as a leading European venture capital firm.
|
Founded Year | Domain | Location | |
|
Investment in early-stage medical device and life science companies with network support.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MyoPowers Medical Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MyoPowers Medical Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Myopowers Medical Technologies Comparisons
Competitors of MyoPowers Medical Technologies
MyoPowers Medical Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Amber Therapeutics, NeuSpera Medical, UroMems and Levee Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| domain | founded_year | HQ Location |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| domain | founded_year | HQ Location |
Developer of active implantable devices for urological incontinence
|
|
| domain | founded_year | HQ Location |
Urological devices for post-prostatectomy incontinence are developed by Levee Medical.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Myopowers Medical Technologies
Frequently Asked Questions about MyoPowers Medical Technologies
When was MyoPowers Medical Technologies founded?
MyoPowers Medical Technologies was founded in 2004 and raised its 1st funding round 6 years after it was founded.
Where is MyoPowers Medical Technologies located?
MyoPowers Medical Technologies is headquartered in Besancon, France.
Is MyoPowers Medical Technologies a funded company?
MyoPowers Medical Technologies is a funded company, having raised a total of $32.99M across 5 funding rounds to date. The company's 1st funding round was a Series B of $4.22M, raised on May 01, 2010.
What does MyoPowers Medical Technologies do?
MyoPowers Medical Technologies was founded in 2004 in Besancon, France, focusing on medical technologies for muscle support in gastrointestinal, cardiology, and urology sectors. Operations center on the development of ARTUS, an implantable device addressing stress urinary incontinence. The device features a smooth silicon cuff positioned around the urethra, with individual adjustability enabled by two remote controlsone for patient voiding and another for surgeon monitoring and adaptation.
Who are the top competitors of MyoPowers Medical Technologies?
MyoPowers Medical Technologies's top competitors include Axonics, NeuSpera Medical and Amber Therapeutics.
Who are MyoPowers Medical Technologies's investors?
MyoPowers Medical Technologies has 6 investors. Key investors include Bpifrance, Truffle Capital, Novartis Venture Fund, BlueOcean Ventures, and Initiative Capital.